Cargando…

Platelet Activation Markers in Children with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease

The study aimed to evaluate mean platelet volume (MPV), platelet distribution width (PDW), and platecrit in children with pulmonary arterial hypertension associated with congenital heart disease (PAH-CHD), to assess the predictive value of these platelet activation markers for adverse outcomes, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Awad, Abdulhalim, Elnemr, Shimaa, Hodeib, Hossam, El Amrousy, Doaa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293825/ https://www.ncbi.nlm.nih.gov/pubmed/35234994 http://dx.doi.org/10.1007/s00246-022-02847-7

Ejemplares similares

Prognostic value of homocysteine and highly sensitive cardiac troponin T in children with acute heart failure
por: El-Amrousy, Doaa, et al.
Publicado: (2018)

Predictive value of P-wave and QT interval dispersion in children with congenital heart disease and pulmonary arterial hypertension for the occurrence of arrhythmias
por: Saleh, Asmaa, et al.
Publicado: (2019)

Vitamin D supplementation in adolescents with irritable bowel syndrome: Is it useful? A randomized controlled trial
por: El Amrousy, Doaa, et al.
Publicado: (2018)

Baseline characteristics and analysis of predictors of the Outcome of septic pulmonary embolism in children: a retrospective observational study
por: Elmeazawy, Rehab, et al.
Publicado: (2023)

Predictive Value of Plasma Copeptin Level in Children with Acute Heart Failure
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Effect of Dexmedetomidine on Pulmonary Artery Pressure in Children with Congenital Heart Disease and Pulmonary Hypertension
por: Kanchi, Muralidhar, et al.
Publicado: (2020)

Idiopathic Pulmonary Arterial Hypertension and Pulmonary Arterial Hypertension Associated With Congenital Heart Disease in Chinese Children: Similarities, Differences, and Prognostic Factors
por: Gu, Li, et al.
Publicado: (2020)

Pulmonary arterial hypertension populations of special interest: portopulmonary hypertension and pulmonary arterial hypertension associated with congenital heart disease
por: Savale, Laurent, et al.
Publicado: (2019)

Riociguat for pulmonary arterial hypertension associated with congenital heart disease
por: Rosenkranz, Stephan, et al.
Publicado: (2015)

Evaluation and Management of Pulmonary Arterial Hypertension in Congenital Heart Disease
por: Arshad, Hassaan B., et al.
Publicado: (2021)

Segmental Pulmonary Hypertension in Children with Congenital Heart Disease
por: Das, Bibhuti B., et al.
Publicado: (2020)

The relationship between endothelial progenitor cells and pulmonary arterial hypertension in children with congenital heart disease
por: Sun, Hong-Xiao, et al.
Publicado: (2019)

Identification of potential serum biomarkers for congenital heart disease children with pulmonary arterial hypertension by metabonomics
por: Jin, Nan, et al.
Publicado: (2023)

Better Outcomes in Pulmonary Arterial Hypertension After Repair of Congenital Heart Disease, Compared With Idiopathic Pulmonary Arterial Hypertension
por: Xu, Zhuoyuan, et al.
Publicado: (2021)

Subcutaneous treprostinil in congenital heart disease-related pulmonary arterial hypertension
por: Skoro-Sajer, Nika, et al.
Publicado: (2018)

Management dilemmas in pulmonary arterial hypertension associated with congenital heart disease
por: Condliffe, R., et al.
Publicado: (2018)

The Changing Landscape of Pulmonary Arterial Hypertension in the Adult with Congenital Heart Disease
por: van Dissel, Alexandra C., et al.
Publicado: (2017)

Pulmonary arterial hypertension associated with congenital heart disease: An omics study
por: Zhao, Maolin, et al.
Publicado: (2023)

Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with congenital heart disease
por: Lopes, Antonio, et al.
Publicado: (2014)

Insulin resistance, leptin and adiponectin in lean and hypothyroid children and adolescents with obesity
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Does Inhaled Milrinone Facilitate Weaning From Cardiopulmonary Bypass in Children with Congenital Heart Diseases Complicated with Pulmonary Arterial Hypertension?
por: Elbaser, Ibrahim Ibrahim Abd, et al.
Publicado: (2020)

Pulmonary hypertension in congenital heart disease
por: Pascall, Emma, et al.
Publicado: (2018)

Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension
por: Pfarr, Nicole, et al.
Publicado: (2013)

Altered Lung Microbiome and Metabolome Profile in Children With Pulmonary Arterial Hypertension Associated With Congenital Heart Disease
por: Ma, Runwei, et al.
Publicado: (2022)

MicroRNA-98 can serve as a diagnostic marker for congenital heart disease-associated pulmonary artery hypertension
por: Zhang, Yao-Zhong, et al.
Publicado: (2020)

Recent progress in treatment of pulmonary arterial hypertension due to congenital heart disease
por: Schuuring, M. J., et al.
Publicado: (2011)

Plasma Proteomic Study in Pulmonary Arterial Hypertension Associated with Congenital Heart Diseases
por: Zhang, Xi, et al.
Publicado: (2016)

Effect of iloprost on biomarkers in patients with congenital heart disease‐pulmonary arterial hypertension
por: Li, Xiao‐ye, et al.
Publicado: (2017)

Intravenous sildenafil for postoperative pulmonary hypertension in children with congenital heart disease
por: Fraisse, Alain, et al.
Publicado: (2010)

Adherence to the Mediterranean Diet Improved Clinical Scores and Inflammatory Markers in Children with Active Inflammatory Bowel Disease: A Randomized Trial
por: El Amrousy, Doaa, et al.
Publicado: (2022)

Comprehensive assessments of pulmonary circulation in children with pulmonary hypertension associated with congenital heart disease
por: Muneuchi, Jun, et al.
Publicado: (2022)

Medical Image-Based Hemodynamic Analyses in a Study of the Pulmonary Artery in Children With Pulmonary Hypertension Related to Congenital Heart Disease
por: Wang, Liping, et al.
Publicado: (2020)

MicroRNA-204 as an Indicator of Severity of Pulmonary Hypertension in Children with Congenital Heart Disease Complicated with Pulmonary Hypertension
por: Li, Xu, et al.
Publicado: (2019)

The expression of survivin in irreversible pulmonary arterial hypertension rats and its value in evaluating the reversibility of pulmonary arterial hypertension secondary to congenital heart disease
por: Li, Gang, et al.
Publicado: (2019)

Rare variants in SOX17 are associated with pulmonary arterial hypertension with congenital heart disease
por: Zhu, Na, et al.
Publicado: (2018)

Risk Assessment Tool Implementation in Congenital Heart Disease-Associated Pulmonary Arterial Hypertension
por: Yaylalı, Yalın Tolga, et al.
Publicado: (2023)

Pulmonary vasodilators can lead to various complications in pulmonary “arterial” hypertension associated with congenital heart disease
por: Chida-Nagai, Ayako, et al.
Publicado: (2020)

Nitric oxide synthases in infants and children with pulmonary hypertension and congenital heart disease
por: Hoehn, Thomas, et al.
Publicado: (2009)

Predictors of operability in children with severe pulmonary hypertension associated with congenital heart disease
por: Xi, Shi-Bing, et al.
Publicado: (2019)

Advanced therapies for the management of adults with pulmonary arterial hypertension due to congenital heart disease: a systematic review
por: Varela, Daniel L, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cdu2h6pt3l04jcv5a4h9l2v2di